These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11870842)

  • 21. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent.
    Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G
    Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes.
    Luciani A; Olivier JC; Clement O; Siauve N; Brillet PY; Bessoud B; Gazeau F; Uchegbu IF; Kahn E; Frija G; Cuenod CA
    Radiology; 2004 Apr; 231(1):135-42. PubMed ID: 15068944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
    Hijnen NM; Elevelt A; Grüll H
    Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and Size-selective Permeability of the Synovial Membrane of the Temporomandibular Joint of the Mouse Measured by MR Imaging at 7T.
    Yamazaki F; Satoh K; Seo Y
    Magn Reson Med Sci; 2015; 14(2):115-22. PubMed ID: 25500776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins.
    Qiu L; Zhang F; Shi Y; Bai Z; Wang J; Li Y; Lee D; Ingraham C; Feng X; Yang X
    Radiology; 2016 May; 279(2):400-9. PubMed ID: 26599802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1 snapshot FLASH measurement of rat brain glioma: kinetics of the tumor-enhancing contrast agent manganese (III) tetraphenylporphine sulfonate.
    Hoehn-Berlage M; Norris D; Bockhorst K; Ernestus RI; Kloiber O; Bonnekoh P; Leibfritz D; Hossmann KA
    Magn Reson Med; 1992 Oct; 27(2):201-13. PubMed ID: 1461108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of proton T1 on oxymetry using Overhauser enhanced magnetic resonance imaging.
    Matsumoto S; Utsumi H; Aravalluvan T; Matsumoto K; Matsumoto A; Devasahayam N; Sowers AL; Mitchell JB; Subramanian S; Krishna MC
    Magn Reson Med; 2005 Jul; 54(1):213-7. PubMed ID: 15968662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gd(DTPA-BBA) as a contrast agent in magnetic resonance imaging in rats.
    Sheu RS; Jaw TS; Wang YM; Liu GC; Kuo YT; Chue PY
    J Formos Med Assoc; 1999 Jan; 98(1):49-55. PubMed ID: 10063274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model: in vivo magnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy.
    Gao M; Yao N; Huang D; Jiang C; Feng Y; Li Y; Lou B; Peng F; Sun Z; Ni Y; Zhang J
    J Drug Target; 2015 Jun; 23(5):436-43. PubMed ID: 25582132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver.
    Wisner ER; Merisko-Liversidge E; Kellar K; Katzberg RW; Karpinski PH; Amparo EG; Drake C; Griffey SM; Brock JM
    Acad Radiol; 1995 Feb; 2(2):140-7. PubMed ID: 9419538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
    Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
    J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of manganese and iron tetraphenylporphine sulfonates to albumin is relevant to their contrast properties.
    Yushmanov VE; Tominaga TT; Borissevitch IE; Imasato H; Tabak M
    Magn Reson Imaging; 1996; 14(3):255-61. PubMed ID: 8725191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
    Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
    Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR-guided percutaneous intramyocardial injection with an MR-compatible catheter: feasibility and changes in T1 values after injection of extracellular contrast medium in pigs.
    Krombach GA; Pfeffer JG; Kinzel S; Katoh M; Günther RW; Buecker A
    Radiology; 2005 May; 235(2):487-94. PubMed ID: 15858090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.